COVID 19: Natural Products and Traditional Medicines; Opportunity or Threat?
WHO. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020. March 11, 2020. https://www. who.int/dg/speeches/detail/who-directorgeneral-s-opening-remarks-at-the-mediabriefing-on-covid-19---11-march-2020 (accessed March 20, 2020).
Chang Z. The discovery of Qinghaosu (artemisinin) as an effective anti-malaria drug: A unique China story. Sci China Life Sci 2016;59:81-8.
Owens B. 2015 Nobel Prize goes to antiparasitic drug discoverers. Lancet 2015;386:1433.
Xie J et al. Critical care crisis and some recommendations during the COVID-19 epidemic in China. Intensive Care Med 2020;46:837-840.
Ryu HS, Oh HK, Lee JY, Yoon SW. An Overview on the Traditional Chinese Medicine Treatment Guidelines for Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS). J Intern Korean Med 2015;36:335-347.
Cui HT et al. Traditional chinese medicine for treatment of coronavirus disease 2019: a review. Trad Med Res 2020;5:65-73.
Zhang D, Wu K, Zhang X, Deng S, Peng B. In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. J Integr Med 2020;18:152-158.
|Issue||Vol. 6, No. 1 (Winter 2021)|
|Corona virus Integrative Medicine Complementary medicine|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|